SBI Securities’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

SBI Securities’s Portfolio VRPX Stock Details VRPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-108	Closed	-$130	–	4281
2025 Q1	$130	Buy	108 +84	+350%	+$514	﹤0.01%	3368
2024 Q4	$228	Buy	+24	New	+$319	﹤0.01%	3191

Other funds holding VRPX

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SBI Securities's VRPX Position: Q2 2025 in Review

SBI Securities sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q2 2025, closing a stake of 108 shares — an estimated $130 sold.

SBI Securities first reported a position in VRPX in Q4 2024 and held it in 2 quarters. The position peaked at $228 in Q4 2024. 1 fund tracked by Wall St. Rank holds VRPX as of Q2 2025.

SBI Securities reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
SBI Securities sold 108 Virpax Pharmaceuticals, Inc. Common Stock shares in Q2 2025, an estimated $130.
SBI Securities first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q4 2024 and held it in 2 quarters.
SBI Securities's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $228 in Q4 2024.
1 fund tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.